Sep 22, 2026 08:31AM
Sep 22, 2026 08:30AM
Sep 16, 2026 08:30AM
Aug 27, 2026 08:30AM
Aug 27, 2026 08:30AM
Aug 27, 2026 08:30AM
Aug 12, 2026 08:32AM Propanc Biopharma plans Phase 1b trial for cancer drug PRP
Aug 12, 2026 08:30AM
Aug 6, 2026 08:31AM
Aug 6, 2026 08:31AM
Aug 6, 2026 08:30AM
Aug 6, 2026 08:30AM
Jul 7, 2026 08:33AM
Jul 7, 2026 08:30AM Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
Jun 11, 2026 08:30AM
Jun 11, 2026 08:30AM
Mar 3, 2026 08:46AM
Mar 3, 2026 08:45AM
Mar 3, 2026 08:45AM
Feb 5, 2026 08:45AM
Feb 5, 2026 08:45AM Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
Jan 15, 2026 08:45AM
Jan 15, 2026 08:45AM
Aug 21, 2024 09:00AM
Aug 14, 2024 09:00AM
Jul 17, 2024 09:00AM
Jun 25, 2024 09:00AM
Apr 16, 2024 09:00AM Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Feb 22, 2024 08:00AM
Dec 13, 2023 09:00AM
Nov 7, 2023 09:00AM
Aug 15, 2023 08:30AM
Jul 13, 2023 08:30AM
Jul 5, 2023 09:00AM
Jun 22, 2023 09:00AM Propanc Biopharma Provides Shareholder Update
Mar 28, 2023 09:03AM
Mar 28, 2023 09:00AM
Mar 16, 2023 09:00AM
Dec 15, 2022 09:00AM
Nov 30, 2022 09:00AM
Nov 15, 2022 09:00AM
Oct 26, 2022 09:00AM Propanc Biopharma’s CEO to Present at Sidoti & Company Micro-Cap Virtual Investor Conference
Sep 29, 2022 09:00AM
Sep 13, 2022 09:00AM
Sep 8, 2022 09:15AM
Aug 16, 2022 09:00AM
Aug 3, 2022 09:00AM
Jul 28, 2022 09:00AM
Jul 12, 2022 09:00AM Propanc Biopharma’s CEO Believes Lead Asset Could Unlock Value as PRP Advances to Phase I, First-In-Human Study in Advanced Cancer Patients
Jul 5, 2022 09:00AM

332,359 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All